There are GEM models matching many of the common alterations observed in human prostate tumors, includingMYC overexpression70,91,Pten loss79,92,ERG overexpression81,86,93, andSPOP mutation82 (Figure 2A). This evidence concerns the gene PTEN and prostate neoplasm.